Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2011 (2011), Article ID 981316, 6 pages
http://dx.doi.org/10.1155/2011/981316
Case Report

Complicated Community-Acquired Staphylococcus Endocarditis and Multiple Lung Abscesses: Case Report and Review of Literature

1Division of Infectious Diseases, Department of Medicine, King Fahad Medical City, Riyadh 11525, Saudi Arabia
2Division of Pulmonology, Department of Medicine, Ahmadu Bello University, Zaria, Nigeria

Received 30 May 2011; Accepted 26 June 2011

Academic Editors: E. M. Stringer and P. O. Sumba

Copyright © 2011 Musa A. Garbati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Lautenschlager, C. Herzog, and W. Zimmerli, “Course and outcome of bacteremia due to Staphylococcus aureus: evaluation of different clinical case definitions,” Clinical Infectious Diseases, vol. 16, no. 4, pp. 567–573, 1993. View at Google Scholar · View at Scopus
  2. P. B. Iannini and K. Crossley, “Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection,” Annals of Internal Medicine, vol. 84, no. 5, pp. 558–560, 1976. View at Google Scholar · View at Scopus
  3. J. M. Mylotte, T. R. Beam Jr., and J. C. Allen, “Staphylococcus aureus bacteremia: a prospective study,” Southern Medical Journal, vol. 76, no. 9, pp. 1131–1135, 1983. View at Google Scholar · View at Scopus
  4. D. Z. Uslan, S. J. Crane, J. M. Steckelberg et al., “Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota,” Archives of Internal Medicine, vol. 167, no. 8, pp. 834–839, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. I. M. Tleyjeh, J. M. Steckelberg, H. S. Murad et al., “Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota,” JAMA Journal, vol. 293, no. 24, pp. 3022–3028, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. V. G. Fowler Jr., J. M. Miro, B. Hoen et al., “Staphylococcus aureus endocarditis: a consequence of medical progress,” JAMA Journal, vol. 293, no. 24, pp. 3012–3021, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. A. C. Crémieux, O. Dumitrescu, G. Lina et al., “Panton-valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis,” PLoS ONE, vol. 4, no. 9, Article ID e7204, 2009. View at Publisher · View at Google Scholar · View at PubMed
  8. C. von Eiff, K. Becker, K. Machka, H. Stammer, and G. Peters, “Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group,” New England Journal of Medicine, vol. 344, no. 1, pp. 11–16, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. F. D. Lowy, “Staphylococcus aureus infections,” New England Journal of Medicine, vol. 339, no. 8, pp. 520–532, 1998. View at Google Scholar
  10. V. G. Fowler Jr., A. Justice, C. Moore et al., “Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia,” Clinical Infectious Diseases, vol. 40, no. 5, pp. 695–703, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. R. Finkelstein, J. D. Sobel, A. Nagler, and D. Merzbach, “Staphylococcus aureus bacteremia and endocarditis: comparison of nosocomial and community-acquired infection,” Journal of Medicine, vol. 15, no. 3, pp. 193–211, 1984. View at Google Scholar · View at Scopus
  12. M. B. Ing, L. M. Baddour, and A. S. Bayer, “Bacteremia and infective endocarditis: pathogenesis, diagnosis, and complications,” in The Staphylococci in Human Disease, K. B. Crossley and G. L. Archer, Eds., p. 331, Churchill Livingstone, New York, NY, USA, 1997. View at Google Scholar
  13. V. G. Fowler Jr., M. K. Olsen, G. R. Corey et al., “Clinical identifiers of complicated Staphylococcus aureus bacteremia,” Archives of Internal Medicine, vol. 163, no. 17, pp. 2066–2072, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. P. A. Willcox, B. L. Rayner, and D. A. Whitelaw, “Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs,” QJM Journal, vol. 91, no. 1, pp. 41–47, 1998. View at Google Scholar · View at Scopus
  15. C. M. Nolan and H. N. Beaty, “Staphylococcus aureus bacteremia,” American Journal of Medicine, vol. 60, no. 4, pp. 495–500, 1976. View at Google Scholar · View at Scopus
  16. H. F. Chambers, O. M. Korzeniowski, and M. A. Sande, “Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts,” Medicine, vol. 62, no. 3, pp. 170–177, 1983. View at Google Scholar · View at Scopus
  17. F. Espersen and N. Frimodt-Moller, “Staphylococcus aureus endocarditis: a review of 119 cases,” Archives of Internal Medicine, vol. 146, no. 6, pp. 1118–1121, 1986. View at Google Scholar · View at Scopus
  18. O. Korzeniowski and M. A. Sande, “Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts,” Annals of Internal Medicine, vol. 97, no. 4, pp. 496–503, 1982. View at Google Scholar · View at Scopus
  19. L. A. Mortara and A. S. Bayer, “Staphylococcus aureus bacteremia and endocarditis,” Infectious Disease Clinics of North America, vol. 7, no. 1, pp. 53–68, 1993. View at Google Scholar · View at Scopus
  20. J. M. Mylotte, C. McDermott, and J. A. Spooner, “Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia,” Reviews of Infectious Diseases, vol. 9, no. 5, pp. 891–907, 1987. View at Google Scholar · View at Scopus
  21. B. L. Røder, D. A. Wandall, N. Frimodt-Møller, F. Espersen, P. Skinhøj, and V. T. Rosdahl, “Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark,” Archives of Internal Medicine, vol. 159, no. 5, pp. 462–469, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Nandakumar and G. Raju, “Isolated tricuspid valve endocarditis in nonaddicted patients: a diagnostic challenge,” American Journal of the Medical Sciences, vol. 314, no. 3, pp. 207–212, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. V. A. Papapanagiotou, M. G. Foukarakis, J. N. Fotiadis, E. P. Matsakas, and A. A. Zacharoulis, “Native tricuspid valve endocarditis in a young woman,” Postgraduate Medical Journal, vol. 74, no. 876, pp. 637–638, 1998. View at Google Scholar · View at Scopus
  24. S. P. Clifford, S. J. Eykyn, and C. M. Oakley, “Staphylococcal tricuspid valve endocarditis in patients with structurally normal hearts and no evidence of narcotic abuse,” Quarterly Journal of Medicine, vol. 87, no. 12, pp. 755–757, 1994. View at Google Scholar · View at Scopus
  25. J. C. Castillo, M. P. Anguita, F. Torres, J. R. Siles, D. Mesa, and F. Vallés, “Factores de riesgo asociados a endocarditis sin cardiopatía predisponente,” Revista Española de Cardiología, vol. 55, no. 3, pp. 304–307, 2002. View at Google Scholar
  26. J. M. Mesa, J. Oliver, F. Domínguez et al., “Endocarditis infecciosa derecha. Experiencia de una serie de 35 pacientes,” Revista Espanola de Cardiologia, vol. 43, no. 1, pp. 13–17, 1990. View at Google Scholar · View at Scopus
  27. L. M. Baddour, W. R. Wilson, A. S. Bayer et al., “Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association,” Circulation., vol. 111, no. 23, pp. e394–e433, 2005. View at Google Scholar · View at Scopus
  28. Z. Shimoni, S. Pitlik, M. Szyper-Kravitz, A. Sagie, and J. Bishara, “Tricuspid valve endocarditis in adult patients without known predisposing factors,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 20, no. 1, pp. 49–51, 2001. View at Google Scholar · View at Scopus
  29. R. Nandakumar and G. Raju, “Isolated tricuspid valve endocarditis in nonaddicted patients: a diagnostic challenge,” American Journal of the Medical Sciences, vol. 314, no. 3, pp. 207–212, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. E. E. Hill, S. Vanderschueren, J. Verhaegen et al., “Risk factors for infective endocarditis and outcome of patients with Staphylococcus aureus bacteremia,” Mayo Clinic Proceedings, vol. 82, no. 10, pp. 1165–1169, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Horstkotte, F. Follath, E. Gutschik et al., “Guidelines on prevention, diagnosis and treatment of infective endocarditis. Executive summary. The task force on infective endocarditis of the European society of cardiology,” European Heart Journal, vol. 25, no. 3, pp. 267–276, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. I. M. Tleyjeh and L. M. Baddour, “Staphylococcus aureus bacteremia and infective endocarditis: old questions, new answers?” Mayo Clinic Proceedings, vol. 82, no. 10, pp. 1163–1164, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. H. F. Chambers, R. T. Miller, and M. D. Newman, “Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy,” Annals of Internal Medicine, vol. 109, no. 8, pp. 619–624, 1988. View at Google Scholar · View at Scopus
  34. M. J. DiNubile, “Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users,” Annals of Internal Medicine, vol. 121, no. 11, pp. 873–876, 1994. View at Google Scholar · View at Scopus
  35. J. Fortún, E. Navas, J. Martínez-Beltrán et al., “Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin,” Clinical Infectious Diseases, vol. 33, no. 1, pp. 120–125, 2001. View at Publisher · View at Google Scholar · View at PubMed
  36. E. Ribera, J. Gómez-Jimenez, E. Cortes et al., “Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis: a randomized, controlled trial,” Annals of Internal Medicine, vol. 125, no. 12, pp. 969–974, 1996. View at Google Scholar · View at Scopus
  37. M. Torres-Tortosa, M. de Cueto, A. Vergara et al., “Prospective evaluation of a two-week course of intravenous Antibiotics in intravenous drug addicts with infective endocarditis: study group for infectious diseases of the province of cadiz,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 13, no. 7, pp. 559–564, 1994. View at Publisher · View at Google Scholar
  38. A. Carozza, A. Renzulli, M. de Feo et al., “Tricuspid repair for infective endocarditis: clinical and echocardiographic results,” Texas Heart Institute Journal, vol. 28, no. 2, pp. 96–101, 2001. View at Google Scholar
  39. M. J. Robbins, R. Soeiro, W. H. Frishman, and J. A. Strom, “Right-sided endocarditis: aetiology, diagnosis and an approach to therapy,” American Heart Journal, vol. 111, no. 1, pp. 128–135, 1986. View at Google Scholar
  40. T. Paleček, A. Linhart, J. C. Lubanda, P. Nedbal, J. Humhal, and M. Aschermann, “Infectious 'ARO valve endocarditis trikuspida'lni° grind' Streptococcus agalactiae, imitujı'cı 'tumor rights' sı'ne,” Cor Vasa, vol. 43, pp. 145–148, 2001. View at Google Scholar